Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9533419 | 1.00 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2MEN1KMT2ANPC1 | |
| SCHEMBL9535919 | 0.75 | — | — | |
| SCHEMBL9535922 | 0.75 | — | — | |
| SCHEMBL5853961 | 0.74 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL5853965 | 0.74 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL11304946 | 0.73 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL11304948 | 0.73 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL10718860 | 0.72 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL10718854 | 0.72 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL11219198 | 0.72 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0377528-B1 | Piperidines, process for their preparation and pharmaceutical compounds containing them | LIPHA (FR) | 1993-12-08 | — | — | EP | disclosed |
| US-5001134-A | Piperidines, processes of preparation and medications containing them | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1991-03-19 | — | — | US | disclosed |
| EP-0377528-A1 | Piperidines, process for their preparation and pharmaceutical compounds containing them | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1990-07-11 | — | — | EP | disclosed |
| US-4440775-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-04-03 | — | — | US | disclosed |
| US-4347250-A | ANTIHISTAMINES; ANTISECRETORY, CARDIOTONIC, AND ANTI-INFLAMMATORY AGENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1982-08-31 | — | — | US | disclosed |
| US-4333946-A | ANTIINFLAMMATORY AGENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1982-06-08 | — | — | US | disclosed |
| US-4276301-A | HISTAMINE ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1981-06-30 | — | — | US | disclosed |
| US-4247558-A | HISTAMINE ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1981-01-27 | — | — | US | disclosed |
| US-4192879-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-03-11 | — | — | US | disclosed |
| US-4166856-A | Thiazole and isothiazole derivative as blockers of histamine H2 -receptors | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-09-04 | — | — | US | disclosed |
| US-4098898-A | N-SUBSTITUTED-N'-HETEROCYCLIC ALKYLTHIOUREAS, GUANIDINES, AND ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1978-07-04 | — | — | US | disclosed |